Deerfield Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.5M	Hold	67,935	–	–	0.27%	58
2025 Q4	$27M	Hold	67,935	–	–	0.35%	55
2025 Q3	$31M	Sell	67,935 -77,065	-53%	-$31.4M	0.47%	49
2025 Q2	$47.3M	Hold	145,000	–	–	0.86%	28
2025 Q1	$39.2M	Sell	145,000 -191	-0.1%	-$49.1K	0.78%	29
2024 Q4	$34.2M	Buy	145,191 +191	+0.1%	+$50.2K	0.65%	37
2024 Q3	$39.9M	Buy	145,000 +25,200	+21%	+$6.56M	0.6%	36
2024 Q2	$29.1M	Buy	+119,800	New	+$18.9M	0.48%	43
2024 Q1	–	Sell	-1,574	Closed	-$301K	–	371
2023 Q4	$301K	Buy	+1,574	New	+$268K	0.01%	121
2018 Q3	–	Sell	-146,000	Closed	-$14.4M	–	104
2018 Q2	$14.4M	Hold	146,000	–	–	0.51%	70
2018 Q1	$17.4M	Buy	+146,000	New	+$18.8M	0.62%	60
2016 Q3	–	Sell	-336,000	Closed	-$18.6M	–	92
2016 Q2	$18.6M	Buy	+336,000	New	+$21.2M	0.73%	46
2014 Q3	–	Sell	-100,000	Closed	-$6.32M	–	132
2014 Q2	$6.32M	Sell	100,000 -202,000	-67%	-$12M	0.28%	83
2014 Q1	$20.3M	Buy	+302,000	New	+$23.4M	0.93%	40
2013 Q4	–	Sell	-383,158	Closed	-$24.5M	–	109
2013 Q3	$24.5M	Sell	383,158 -310,842	-45%	-$15.5M	1.24%	39
2013 Q2	$21.5M	Buy	+694,000	New	+$18.5M	1.1%	40